Strain SummaryC57BL/6J-ApcMin/+

Strain Name

C57BL/6J-ApcMin/+

Strain Type(s)

chemically induced mutation

Strain Synonym(s)

ApcMin  •  ApcMin/+  •  APCmin/+  •  APCMin/+  •  APCMin/+  •  B6-ApcMin  •  B6-ApcMin/Apc+  •  B6 Min/+  •  C57BL/6 ApcMin/+  •  C57Bl/6-Min  •  C57BL/6-Min  •  C57BL/6J-ApcMin/+  •  C57BL/6J-APCMin/+  •  C57BL/6J/-ApcMin  •  C57BL/6J-APCmin/+  •  C57BL/6J-ApcMin/J  •  C57BL/6J ApcMin/+  •  C57BL/6J-ApcMin/+  •  C57BL/6J APCMin/+  •  C57BL/6J Apcmin  •  C57BL/6J-ApcMin  •  C57BL/6J ApcMin/+  •  C57BL/6J-ApcMin  •  C57BL/6J-ApcMin/+  •  C57BL/6J-APCMin/+  •  C57BL/6J-ApcMin/J  •  C57Bl/6J-Min/+  •  C57BL/6J Min  •  C57BL/6J Min/+  •  C57BL/6J-Min  •  C57BL/6J-Min/+  •  C57BL/6J/Min/+  •  C57Bl/6J-Min+  •  C57BL/6J Min  •  C57BL/6J Min /+  •  C57BL/6J-Min/+  •  C57Bl/6JMin/+  •  C57Bl/6-Min/+  •  C57BL/6-Min  •  adenomatous polyposis coliMin/+  •  Apc+/-  •  Apc+/- Msh2+/+  •  ApcMin/+  •  ApcMin/+  •  APCMin/+  •  Apcmin  •  ApcMin  •  ApcMin heterozygous  •  ApcMin  •  ApcMin/Apc+  •  ApcMin  •  ApcMin/+  •  APCMin/+  •  Min  •  Min/+  •  Min C57BL/6J  •  Min/+ C57BL/6J  •  Min  •  Min/+  •  multiple intestinal neoplasia

Description

Heterozygous mice - "Min" mutation

Strain Links

• JAX Mice

Strain Genetics

ApcMin / Apc+

Models

211 unique models displayed. A model is a set of tumors that share the same tumor name, organ(s) affected, and treatment type for a specific strain.
Frequency
Model Name Organ Affected Tumor Inducing Agent(s) Female Male Mixed Pop. Unspecified Additional Information Model Details
Intestine - Large Intestine - Colon adenocarcinoma Intestine - Large Intestine - Colon BRL-49,653, PPAR gamma ligand

observed

References: Lefebvre AM, Nat Med 1998 Sep;4(9):1053-7

Intestine - Large Intestine - Colon adenoma Intestine - Large Intestine - Colon

observed - 100

observed - 100

0 - observed

References: Andrijes R, Proc Natl Acad Sci U S A 2021 Sep 28;118(39):   ⋅   Bjerknes M, Am J Pathol 1999 Jun;154(6):1831-4   ⋅   Chen Q, Life Sci Alliance 2021 Mar;4(3):   ⋅   Ritland SR, Cancer Res 2000 Sep 1;60(17):4678-81   ⋅   Schmelz EM, Cancer Res 2001 Sep 15;61(18):6723-9   ⋅   Shattuck-Brandt RL, Mol Carcinog 1999 Mar;24(3):177-87   ⋅   Wilson CL, Proc Natl Acad Sci U S A 1997 Feb 18;94(4):1402-7   ⋅   Woo DK, Am J Pathol 2012 Jan;180(1):24-31   ⋅   Xie G, JCI Insight 2022 Feb 22;7(4):e150894

3 pathology image(s)

Intestine - Large Intestine - Colon adenoma Intestine - Large Intestine - Colon N-[4-(3-chloro-4-fluoro-phenylamino)-quinazolin-6-yl]acrylamide (CFPQA)

observed

References: Ritland SR, Cancer Res 2000 Sep 1;60(17):4678-81

Intestine - Large Intestine - Colon adenoma Intestine - Large Intestine - Colon ceramide (N-palmitoylsphingosine)

observed

References: Schmelz EM, Cancer Res 2001 Sep 15;61(18):6723-9

Intestine - Large Intestine - Colon adenoma Intestine - Large Intestine - Colon sphingolipid mix

observed

References: Schmelz EM, Cancer Res 2001 Sep 15;61(18):6723-9

Intestine - Large Intestine - Colon adenoma Intestine - Large Intestine - Colon sphingolipid mix   ⋅   ceramide (N-palmitoylsphingosine)

observed

References: Schmelz EM, Cancer Res 2001 Sep 15;61(18):6723-9

Intestine - Large Intestine - Colon adenoma Intestine - Large Intestine - Colon piroxicam

observed

References: Ritland SR, Cancer Res 2000 Sep 1;60(17):4678-81

Intestine - Large Intestine - Colon adenoma - dysplastic Intestine - Large Intestine - Colon tamoxifen (for inducing expression from mutant alleles)

observed

References: Powell AE, Am J Physiol Gastrointest Liver Physiol 2014 Jul 1;307(1):G16-23

Intestine - Large Intestine - Colon adenoma - tubular Intestine - Large Intestine - Colon

observed

References: Lefebvre AM, Nat Med 1998 Sep;4(9):1053-7

Intestine - Large Intestine - Colon adenoma - tubular Intestine - Large Intestine - Colon tamoxifen (for inducing expression from mutant alleles)

observed

References: Powell AE, Am J Physiol Gastrointest Liver Physiol 2014 Jul 1;307(1):G16-23

Intestine - Large Intestine - Colon dysplasia - high grade Intestine - Large Intestine - Colon

0

References: Andrijes R, Proc Natl Acad Sci U S A 2021 Sep 28;118(39):

Intestine - Large Intestine - Colon dysplasia - low grade Intestine - Large Intestine - Colon

15.79

References: Andrijes R, Proc Natl Acad Sci U S A 2021 Sep 28;118(39):

Intestine - Large Intestine - Colon foci - aberrant crypt (ACF) Intestine - Large Intestine - Colon 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)

observed - 93

References: Steffensen IL, Cancer Res 2001 Dec 15;61(24):8689-96

Intestine - Large Intestine - Colon foci - aberrant crypt (ACF) Intestine - Large Intestine - Colon

86 - 90

observed

References: Steffensen IL, Cancer Res 2001 Dec 15;61(24):8689-96   ⋅   Zheng W, Int J Cancer 2012 Jan 1;130(1):10-9

Intestine - Large Intestine - Colon polyp Intestine - Large Intestine - Colon polyethylene glycol

observed

References: Shailubhai K, Cancer Res 2000 Sep 15;60(18):5151-7

Intestine - Large Intestine - Colon polyp Intestine - Large Intestine - Colon uroguanylin   ⋅   polyethylene glycol

0 - observed

References: Shailubhai K, Cancer Res 2000 Sep 15;60(18):5151-7

Intestine - Large Intestine - Colon polyp Intestine - Large Intestine - Colon

observed

observed - 90.91

References: Andrijes R, Proc Natl Acad Sci U S A 2021 Sep 28;118(39):   ⋅   Gupta RA, Nat Med 2004 Mar;10(3):245-7   ⋅   Mutoh M, Cancer Res 2002 Jan 1;62(1):28-32   ⋅   Zeineldin M, Oncogene 2012 May 10;31(19):2423-37

Intestine - Large Intestine - Colon polyp Intestine - Large Intestine - Colon 2-[2-{2-(1-naphthyl)propanoylamino}phenyl]methylbenzoic acid (ONO-AE2-227)

observed

References: Mutoh M, Cancer Res 2002 Jan 1;62(1):28-32

Intestine - Large Intestine - Colon polyp Intestine - Large Intestine - Colon GW501516, PPAR-delta agonist

observed

References: Gupta RA, Nat Med 2004 Mar;10(3):245-7

Intestine - Large Intestine - Colon tumor Intestine - Large Intestine - Colon low fiber

100

References: Pierre F, Cancer Res 1997 Jan 15;57(2):225-8

Intestine - Large Intestine - Colon tumor Intestine - Large Intestine - Colon high fiber

60 - 100

References: Pierre F, Cancer Res 1997 Jan 15;57(2):225-8

Intestine - Large Intestine - Colon tumor Intestine - Large Intestine - Colon

observed

observed

observed - 45

observed

References: Barnes CJ, Gastroenterology 1998 May;114(5):873-7   ⋅   Lefebvre AM, Nat Med 1998 Sep;4(9):1053-7   ⋅   Ma H, Cell Rep 2020 Jan 21;30(3):793-806.e6   ⋅   Mahmoud NN, Carcinogenesis 1999 Feb;20(2):299-303   ⋅   Ritland SR, Clin Cancer Res 1999 Apr;5(4):855-63   ⋅   Shattuck-Brandt RL, Gastroenterology 2000 Feb;118(2):337-45   ⋅   Steffensen IL, Cancer Res 2001 Dec 15;61(24):8689-96   ⋅   Weyant MJ, Cancer Res 2001 Jan 1;61(1):118-25   ⋅   Weyant MJ, Cancer Res 2001 Mar 15;61(6):2547-51

Intestine - Large Intestine - Colon tumor Intestine - Large Intestine - Colon chenodeoxycholate (chenodeoxycholic acid)

observed

References: Mahmoud NN, Carcinogenesis 1999 Feb;20(2):299-303

Intestine - Large Intestine - Colon tumor Intestine - Large Intestine - Colon sulfasalazine (SASP)

observed

References: Ritland SR, Clin Cancer Res 1999 Apr;5(4):855-63

Intestine - Large Intestine - Colon tumor Intestine - Large Intestine - Colon Pentasa

observed

References: Ritland SR, Clin Cancer Res 1999 Apr;5(4):855-63

Intestine - Large Intestine - Colon tumor Intestine - Large Intestine - Colon 5-aminosalicylic acid, free acid (5-ASA)

observed

References: Ritland SR, Clin Cancer Res 1999 Apr;5(4):855-63

Intestine - Large Intestine - Colon tumor Intestine - Large Intestine - Colon (+)-catechin

observed

References: Weyant MJ, Cancer Res 2001 Jan 1;61(1):118-25

Intestine - Large Intestine - Colon tumor Intestine - Large Intestine - Colon ovariectomy

observed

References: Weyant MJ, Cancer Res 2001 Mar 15;61(6):2547-51

Intestine - Large Intestine - Colon tumor Intestine - Large Intestine - Colon 17beta-estradiol (E2)   ⋅   ovariectomy

observed

References: Weyant MJ, Cancer Res 2001 Mar 15;61(6):2547-51

Intestine - Large Intestine - Colon tumor Intestine - Large Intestine - Colon 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)

observed - 88

References: Steffensen IL, Cancer Res 2001 Dec 15;61(24):8689-96

Intestine - Large Intestine - Colon tumor Intestine - Large Intestine - Colon BRL-49,653, PPAR gamma ligand

observed

References: Lefebvre AM, Nat Med 1998 Sep;4(9):1053-7

Intestine - Large Intestine - Colon tumor Intestine - Large Intestine - Colon troglitazone

observed

References: Lefebvre AM, Nat Med 1998 Sep;4(9):1053-7

Intestine - Large Intestine - Colon tumor Intestine - Large Intestine - Colon aspirin (acetylsalicylic acid) (ASA)

observed

References: Barnes CJ, Gastroenterology 1998 May;114(5):873-7

Intestine - Large Intestine - Colon tumor Intestine - Large Intestine - Colon tamoxifen (for inducing expression from mutant alleles)

observed

References: Powell AE, Am J Physiol Gastrointest Liver Physiol 2014 Jul 1;307(1):G16-23

Intestine - Large Intestine - Rectum tumor Intestine - Large Intestine - Rectum

observed

References: Ma H, Cell Rep 2020 Jan 21;30(3):793-806.e6

Intestine - Large Intestine adenocarcinoma Intestine - Large Intestine

0

References: Pino MV, Toxicol Pathol 2004 Jan-Feb;32(1):58-63

Intestine - Large Intestine adenocarcinoma Intestine - Large Intestine NID525, PPAR gamma agonist

0

References: Pino MV, Toxicol Pathol 2004 Jan-Feb;32(1):58-63

Intestine - Large Intestine adenocarcinoma Intestine - Large Intestine troglitazone

6.7

References: Pino MV, Toxicol Pathol 2004 Jan-Feb;32(1):58-63

Intestine - Large Intestine adenocarcinoma Intestine - Large Intestine pioglitazone

0

References: Pino MV, Toxicol Pathol 2004 Jan-Feb;32(1):58-63

Intestine - Large Intestine adenocarcinoma Intestine - Large Intestine rosiglitazone

0

References: Pino MV, Toxicol Pathol 2004 Jan-Feb;32(1):58-63

Intestine - Large Intestine adenoma Intestine - Large Intestine

observed - 54

60 - 67

References: Nakatsugi S, Jpn J Cancer Res 1997 Dec;88(12):1117-20   ⋅   Paulsen JE, Carcinogenesis 1997 Oct;18(10):1905-10   ⋅   Pino MV, Toxicol Pathol 2004 Jan-Feb;32(1):58-63

Intestine - Large Intestine adenoma Intestine - Large Intestine fish oil

25 - 33

50 - 60

References: Paulsen JE, Carcinogenesis 1997 Oct;18(10):1905-10

Intestine - Large Intestine adenoma Intestine - Large Intestine sulindac

10

References: Boolbol SK, Cancer Res 1996 Jun 1;56(11):2556-60

Intestine - Large Intestine adenoma Intestine - Large Intestine NID525, PPAR gamma agonist

100

References: Pino MV, Toxicol Pathol 2004 Jan-Feb;32(1):58-63

Intestine - Large Intestine adenoma Intestine - Large Intestine troglitazone

observed

References: Pino MV, Toxicol Pathol 2004 Jan-Feb;32(1):58-63

Intestine - Large Intestine adenoma Intestine - Large Intestine pioglitazone

100

References: Pino MV, Toxicol Pathol 2004 Jan-Feb;32(1):58-63

Intestine - Large Intestine adenoma Intestine - Large Intestine rosiglitazone

100

References: Pino MV, Toxicol Pathol 2004 Jan-Feb;32(1):58-63

Intestine - Large Intestine adenoma Intestine - Large Intestine nimesulide (4-nitro-2-phenoxymethanesulfonanilide)

observed

References: Nakatsugi S, Jpn J Cancer Res 1997 Dec;88(12):1117-20

Intestine - Large Intestine hyperplasia Intestine - Large Intestine

observed

References: Pino MV, Toxicol Pathol 2004 Jan-Feb;32(1):58-63

Intestine - Large Intestine hyperplasia Intestine - Large Intestine NID525, PPAR gamma agonist

observed

References: Pino MV, Toxicol Pathol 2004 Jan-Feb;32(1):58-63

Intestine - Large Intestine hyperplasia Intestine - Large Intestine troglitazone

observed

References: Pino MV, Toxicol Pathol 2004 Jan-Feb;32(1):58-63

Intestine - Large Intestine hyperplasia Intestine - Large Intestine pioglitazone

observed

References: Pino MV, Toxicol Pathol 2004 Jan-Feb;32(1):58-63

Intestine - Large Intestine hyperplasia Intestine - Large Intestine rosiglitazone

observed

References: Pino MV, Toxicol Pathol 2004 Jan-Feb;32(1):58-63

Intestine - Large Intestine polyp Intestine - Large Intestine

observed - very low

References: Andrijes R, Proc Natl Acad Sci U S A 2021 Sep 28;118(39):   ⋅   Gupta RA, Nat Med 2004 Mar;10(3):245-7   ⋅   Sundberg J, Personal Communication 1997;():

2 pathology image(s)

Intestine - Large Intestine tumor Intestine - Large Intestine

observed - 43

observed - 100

77.78

observed

References: Boolbol SK, Cancer Res 1996 Jun 1;56(11):2556-60   ⋅   Ma H, Cell Rep 2020 Jan 21;30(3):793-806.e6   ⋅   Steffensen IL, Carcinogenesis 1997 May;18(5):1049-54   ⋅   Ton-That H, FEBS Lett 1997 Dec 15;419(2-3):239-43   ⋅   Ziegler CC, J Nutr 2004 Jan;134(1):5-10

Intestine - Large Intestine tumor Intestine - Large Intestine 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)

14

50

References: Steffensen IL, Carcinogenesis 1997 May;18(5):1049-54

Intestine - Large Intestine tumor Intestine - Large Intestine troglitazone

93

References: Pino MV, Toxicol Pathol 2004 Jan-Feb;32(1):58-63

Intestine - Large Intestine tumor Intestine - Large Intestine resveratrol

observed

References: Ziegler CC, J Nutr 2004 Jan;134(1):5-10

Intestine - Small Intestine - Distal adenoma Intestine - Small Intestine - Distal

observed

observed - 100

References: Nakatsugi S, Jpn J Cancer Res 1997 Dec;88(12):1117-20   ⋅   Pino MV, Toxicol Pathol 2004 Jan-Feb;32(1):58-63   ⋅   Schmelz EM, Cancer Res 2001 Sep 15;61(18):6723-9

Intestine - Small Intestine - Distal adenoma Intestine - Small Intestine - Distal ceramide (N-palmitoylsphingosine)

observed

References: Schmelz EM, Cancer Res 2001 Sep 15;61(18):6723-9

Intestine - Small Intestine - Distal adenoma Intestine - Small Intestine - Distal sphingolipid mix

observed

References: Schmelz EM, Cancer Res 2001 Sep 15;61(18):6723-9

Intestine - Small Intestine - Distal adenoma Intestine - Small Intestine - Distal sphingolipid mix   ⋅   ceramide (N-palmitoylsphingosine)

observed

References: Schmelz EM, Cancer Res 2001 Sep 15;61(18):6723-9

Intestine - Small Intestine - Distal adenoma Intestine - Small Intestine - Distal NID525, PPAR gamma agonist

100

References: Pino MV, Toxicol Pathol 2004 Jan-Feb;32(1):58-63

Intestine - Small Intestine - Distal adenoma Intestine - Small Intestine - Distal nimesulide (4-nitro-2-phenoxymethanesulfonanilide)

observed

References: Nakatsugi S, Jpn J Cancer Res 1997 Dec;88(12):1117-20

Intestine - Small Intestine - Distal polyp Intestine - Small Intestine - Distal

observed

References: Mutoh M, Cancer Res 2002 Jan 1;62(1):28-32

Intestine - Small Intestine - Distal polyp Intestine - Small Intestine - Distal 2-[2-{2-(1-naphthyl)propanoylamino}phenyl]methylbenzoic acid (ONO-AE2-227)

observed

References: Mutoh M, Cancer Res 2002 Jan 1;62(1):28-32

Intestine - Small Intestine - Distal tumor Intestine - Small Intestine - Distal 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)

observed

References: Steffensen IL, Cancer Res 2001 Dec 15;61(24):8689-96

Intestine - Small Intestine - Distal tumor Intestine - Small Intestine - Distal BRL-49,653, PPAR gamma ligand

observed

References: Lefebvre AM, Nat Med 1998 Sep;4(9):1053-7

Intestine - Small Intestine - Distal tumor Intestine - Small Intestine - Distal

observed

observed

observed

References: Barnes CJ, Gastroenterology 1998 May;114(5):873-7   ⋅   Lefebvre AM, Nat Med 1998 Sep;4(9):1053-7   ⋅   Xie G, JCI Insight 2022 Feb 22;7(4):e150894

Intestine - Small Intestine - Distal tumor Intestine - Small Intestine - Distal troglitazone

observed - 100

References: Lefebvre AM, Nat Med 1998 Sep;4(9):1053-7   ⋅   Pino MV, Toxicol Pathol 2004 Jan-Feb;32(1):58-63

Intestine - Small Intestine - Distal tumor Intestine - Small Intestine - Distal pioglitazone

100

References: Pino MV, Toxicol Pathol 2004 Jan-Feb;32(1):58-63

Intestine - Small Intestine - Distal tumor Intestine - Small Intestine - Distal rosiglitazone

100

References: Pino MV, Toxicol Pathol 2004 Jan-Feb;32(1):58-63

Intestine - Small Intestine - Distal tumor Intestine - Small Intestine - Distal aspirin (acetylsalicylic acid) (ASA)

observed

References: Barnes CJ, Gastroenterology 1998 May;114(5):873-7

Intestine - Small Intestine - Duodenum adenoma Intestine - Small Intestine - Duodenum piroxicam

observed

References: Ritland SR, Cancer Res 2000 Sep 1;60(17):4678-81

Intestine - Small Intestine - Duodenum adenoma Intestine - Small Intestine - Duodenum N-[4-(3-chloro-4-fluoro-phenylamino)-quinazolin-6-yl]acrylamide (CFPQA)

observed

References: Ritland SR, Cancer Res 2000 Sep 1;60(17):4678-81

Intestine - Small Intestine - Duodenum adenoma Intestine - Small Intestine - Duodenum

observed

References: Ritland SR, Cancer Res 2000 Sep 1;60(17):4678-81

Intestine - Small Intestine - Duodenum lesion Intestine - Small Intestine - Duodenum N-[4-(3-chloro-4-fluoro-phenylamino)-quinazolin-6-yl]acrylamide (CFPQA)

0 - observed

References: Ritland SR, Cancer Res 2000 Sep 1;60(17):4678-81

Intestine - Small Intestine - Duodenum polyp Intestine - Small Intestine - Duodenum polyethylene glycol

observed

References: Shailubhai K, Cancer Res 2000 Sep 15;60(18):5151-7

Intestine - Small Intestine - Duodenum polyp Intestine - Small Intestine - Duodenum uroguanylin   ⋅   polyethylene glycol

observed

References: Shailubhai K, Cancer Res 2000 Sep 15;60(18):5151-7

Intestine - Small Intestine - Duodenum polyp Intestine - Small Intestine - Duodenum

45.45

References: Zeineldin M, Oncogene 2012 May 10;31(19):2423-37

Intestine - Small Intestine - Duodenum tumor Intestine - Small Intestine - Duodenum

observed

observed

References: Boolbol SK, Cancer Res 1996 Jun 1;56(11):2556-60   ⋅   Mahmoud NN, Carcinogenesis 1999 Feb;20(2):299-303   ⋅   Sun X, Mol Cancer 2009;8():73   ⋅   Weyant MJ, Cancer Res 2001 Jan 1;61(1):118-25   ⋅   Weyant MJ, Cancer Res 2001 Mar 15;61(6):2547-51

Intestine - Small Intestine - Duodenum tumor Intestine - Small Intestine - Duodenum chenodeoxycholate (chenodeoxycholic acid)

observed

References: Mahmoud NN, Carcinogenesis 1999 Feb;20(2):299-303

Intestine - Small Intestine - Duodenum tumor Intestine - Small Intestine - Duodenum sulindac

0

References: Boolbol SK, Cancer Res 1996 Jun 1;56(11):2556-60

Intestine - Small Intestine - Duodenum tumor Intestine - Small Intestine - Duodenum polyethylene glycol

30

References: Shailubhai K, Cancer Res 2000 Sep 15;60(18):5151-7

Intestine - Small Intestine - Duodenum tumor Intestine - Small Intestine - Duodenum (+)-catechin

observed

References: Weyant MJ, Cancer Res 2001 Jan 1;61(1):118-25

Intestine - Small Intestine - Duodenum tumor Intestine - Small Intestine - Duodenum ovariectomy

observed

References: Weyant MJ, Cancer Res 2001 Mar 15;61(6):2547-51

Intestine - Small Intestine - Duodenum tumor Intestine - Small Intestine - Duodenum 17beta-estradiol (E2)   ⋅   ovariectomy

observed

References: Weyant MJ, Cancer Res 2001 Mar 15;61(6):2547-51

Intestine - Small Intestine - Ileum adenoma Intestine - Small Intestine - Ileum

observed

observed

References: Paoni NF, Physiol Genomics 2003 Nov 11;15(3):228-35   ⋅   Ritland SR, Cancer Res 2000 Sep 1;60(17):4678-81

Intestine - Small Intestine - Ileum adenoma Intestine - Small Intestine - Ileum N-[4-(3-chloro-4-fluoro-phenylamino)-quinazolin-6-yl]acrylamide (CFPQA)

observed

References: Ritland SR, Cancer Res 2000 Sep 1;60(17):4678-81

Intestine - Small Intestine - Ileum adenoma Intestine - Small Intestine - Ileum piroxicam

observed

References: Ritland SR, Cancer Res 2000 Sep 1;60(17):4678-81

Intestine - Small Intestine - Ileum carcinoma Intestine - Small Intestine - Ileum

observed

References: Paoni NF, Physiol Genomics 2003 Nov 11;15(3):228-35

Intestine - Small Intestine - Ileum polyp Intestine - Small Intestine - Ileum uroguanylin   ⋅   polyethylene glycol

observed

References: Shailubhai K, Cancer Res 2000 Sep 15;60(18):5151-7

Intestine - Small Intestine - Ileum polyp Intestine - Small Intestine - Ileum polyethylene glycol

observed

References: Shailubhai K, Cancer Res 2000 Sep 15;60(18):5151-7

Intestine - Small Intestine - Ileum polyp Intestine - Small Intestine - Ileum

100

References: Zeineldin M, Oncogene 2012 May 10;31(19):2423-37

Intestine - Small Intestine - Ileum tumor Intestine - Small Intestine - Ileum

observed

observed

References: Boolbol SK, Cancer Res 1996 Jun 1;56(11):2556-60   ⋅   Sun X, Mol Cancer 2009;8():73

Intestine - Small Intestine - Ileum tumor Intestine - Small Intestine - Ileum sulindac

0

References: Boolbol SK, Cancer Res 1996 Jun 1;56(11):2556-60

Intestine - Small Intestine - Jejunum adenoma Intestine - Small Intestine - Jejunum

observed

References: Ritland SR, Cancer Res 2000 Sep 1;60(17):4678-81

Intestine - Small Intestine - Jejunum adenoma Intestine - Small Intestine - Jejunum N-[4-(3-chloro-4-fluoro-phenylamino)-quinazolin-6-yl]acrylamide (CFPQA)

observed

References: Ritland SR, Cancer Res 2000 Sep 1;60(17):4678-81

Intestine - Small Intestine - Jejunum adenoma Intestine - Small Intestine - Jejunum piroxicam

observed

References: Ritland SR, Cancer Res 2000 Sep 1;60(17):4678-81

Intestine - Small Intestine - Jejunum polyp Intestine - Small Intestine - Jejunum uroguanylin   ⋅   polyethylene glycol

observed

References: Shailubhai K, Cancer Res 2000 Sep 15;60(18):5151-7

Intestine - Small Intestine - Jejunum polyp Intestine - Small Intestine - Jejunum polyethylene glycol

observed

References: Shailubhai K, Cancer Res 2000 Sep 15;60(18):5151-7

Intestine - Small Intestine - Jejunum polyp Intestine - Small Intestine - Jejunum

100

References: Zeineldin M, Oncogene 2012 May 10;31(19):2423-37

Intestine - Small Intestine - Jejunum tumor Intestine - Small Intestine - Jejunum

observed

observed

References: Boolbol SK, Cancer Res 1996 Jun 1;56(11):2556-60   ⋅   Sun X, Mol Cancer 2009;8():73

Intestine - Small Intestine - Jejunum tumor Intestine - Small Intestine - Jejunum sulindac

0

References: Boolbol SK, Cancer Res 1996 Jun 1;56(11):2556-60

Intestine - Small Intestine - Medial adenoma Intestine - Small Intestine - Medial

observed

observed

References: Nakatsugi S, Jpn J Cancer Res 1997 Dec;88(12):1117-20   ⋅   Schmelz EM, Cancer Res 2001 Sep 15;61(18):6723-9

Intestine - Small Intestine - Medial adenoma Intestine - Small Intestine - Medial ceramide (N-palmitoylsphingosine)

observed

References: Schmelz EM, Cancer Res 2001 Sep 15;61(18):6723-9

Intestine - Small Intestine - Medial adenoma Intestine - Small Intestine - Medial sphingolipid mix

observed

References: Schmelz EM, Cancer Res 2001 Sep 15;61(18):6723-9

Intestine - Small Intestine - Medial adenoma Intestine - Small Intestine - Medial sphingolipid mix   ⋅   ceramide (N-palmitoylsphingosine)

observed

References: Schmelz EM, Cancer Res 2001 Sep 15;61(18):6723-9

Intestine - Small Intestine - Medial adenoma Intestine - Small Intestine - Medial nimesulide (4-nitro-2-phenoxymethanesulfonanilide)

observed

References: Nakatsugi S, Jpn J Cancer Res 1997 Dec;88(12):1117-20

Intestine - Small Intestine - Medial polyp Intestine - Small Intestine - Medial

observed

References: Mutoh M, Cancer Res 2002 Jan 1;62(1):28-32

Intestine - Small Intestine - Medial polyp Intestine - Small Intestine - Medial 2-[2-{2-(1-naphthyl)propanoylamino}phenyl]methylbenzoic acid (ONO-AE2-227)

observed

References: Mutoh M, Cancer Res 2002 Jan 1;62(1):28-32

Intestine - Small Intestine - Medial tumor Intestine - Small Intestine - Medial 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)

observed

References: Steffensen IL, Cancer Res 2001 Dec 15;61(24):8689-96

Intestine - Small Intestine - Medial tumor Intestine - Small Intestine - Medial

observed

observed

observed

References: Barnes CJ, Gastroenterology 1998 May;114(5):873-7   ⋅   Xie G, JCI Insight 2022 Feb 22;7(4):e150894

Intestine - Small Intestine - Medial tumor Intestine - Small Intestine - Medial aspirin (acetylsalicylic acid) (ASA)

observed

References: Barnes CJ, Gastroenterology 1998 May;114(5):873-7

Intestine - Small Intestine - Proximal adenoma Intestine - Small Intestine - Proximal

observed

observed - 100

References: Nakatsugi S, Jpn J Cancer Res 1997 Dec;88(12):1117-20   ⋅   Pino MV, Toxicol Pathol 2004 Jan-Feb;32(1):58-63   ⋅   Schmelz EM, Cancer Res 2001 Sep 15;61(18):6723-9

Intestine - Small Intestine - Proximal adenoma Intestine - Small Intestine - Proximal ceramide (N-palmitoylsphingosine)

observed

References: Schmelz EM, Cancer Res 2001 Sep 15;61(18):6723-9

Intestine - Small Intestine - Proximal adenoma Intestine - Small Intestine - Proximal sphingolipid mix

observed

References: Schmelz EM, Cancer Res 2001 Sep 15;61(18):6723-9

Intestine - Small Intestine - Proximal adenoma Intestine - Small Intestine - Proximal sphingolipid mix   ⋅   ceramide (N-palmitoylsphingosine)

observed

References: Schmelz EM, Cancer Res 2001 Sep 15;61(18):6723-9

Intestine - Small Intestine - Proximal adenoma Intestine - Small Intestine - Proximal NID525, PPAR gamma agonist

100

References: Pino MV, Toxicol Pathol 2004 Jan-Feb;32(1):58-63

Intestine - Small Intestine - Proximal adenoma Intestine - Small Intestine - Proximal nimesulide (4-nitro-2-phenoxymethanesulfonanilide)

observed

References: Nakatsugi S, Jpn J Cancer Res 1997 Dec;88(12):1117-20

Intestine - Small Intestine - Proximal polyp Intestine - Small Intestine - Proximal

observed

References: Mutoh M, Cancer Res 2002 Jan 1;62(1):28-32

Intestine - Small Intestine - Proximal polyp Intestine - Small Intestine - Proximal 2-[2-{2-(1-naphthyl)propanoylamino}phenyl]methylbenzoic acid (ONO-AE2-227)

observed

References: Mutoh M, Cancer Res 2002 Jan 1;62(1):28-32

Intestine - Small Intestine - Proximal tumor Intestine - Small Intestine - Proximal 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)

observed

References: Steffensen IL, Cancer Res 2001 Dec 15;61(24):8689-96

Intestine - Small Intestine - Proximal tumor Intestine - Small Intestine - Proximal BRL-49,653, PPAR gamma ligand

observed

References: Lefebvre AM, Nat Med 1998 Sep;4(9):1053-7

Intestine - Small Intestine - Proximal tumor Intestine - Small Intestine - Proximal

observed

observed

observed

References: Barnes CJ, Gastroenterology 1998 May;114(5):873-7   ⋅   Lefebvre AM, Nat Med 1998 Sep;4(9):1053-7   ⋅   Xie G, JCI Insight 2022 Feb 22;7(4):e150894

Intestine - Small Intestine - Proximal tumor Intestine - Small Intestine - Proximal troglitazone

observed - 100

References: Lefebvre AM, Nat Med 1998 Sep;4(9):1053-7   ⋅   Pino MV, Toxicol Pathol 2004 Jan-Feb;32(1):58-63

Intestine - Small Intestine - Proximal tumor Intestine - Small Intestine - Proximal pioglitazone

100

References: Pino MV, Toxicol Pathol 2004 Jan-Feb;32(1):58-63

Intestine - Small Intestine - Proximal tumor Intestine - Small Intestine - Proximal rosiglitazone

100

References: Pino MV, Toxicol Pathol 2004 Jan-Feb;32(1):58-63

Intestine - Small Intestine - Proximal tumor Intestine - Small Intestine - Proximal aspirin (acetylsalicylic acid) (ASA)

observed

References: Barnes CJ, Gastroenterology 1998 May;114(5):873-7

Intestine - Small Intestine adenoma Intestine - Small Intestine

observed - 100

very high - 100

observed - 100

observed - 94.74

References: Andrijes R, Proc Natl Acad Sci U S A 2021 Sep 28;118(39):   ⋅   Chen Q, Life Sci Alliance 2021 Mar;4(3):   ⋅   Paulsen JE, Carcinogenesis 1997 Oct;18(10):1905-10   ⋅   Qi C, Int J Biol Sci 2015;11(6):679-87   ⋅   Shattuck-Brandt RL, Mol Carcinog 1999 Mar;24(3):177-87   ⋅   Steffensen IL, Carcinogenesis 1997 May;18(5):1049-54   ⋅   Weyant MJ, Cancer Res 2001 Mar 15;61(6):2547-51   ⋅   Wilson CL, Proc Natl Acad Sci U S A 1997 Feb 18;94(4):1402-7   ⋅   Woo DK, Am J Pathol 2012 Jan;180(1):24-31   ⋅   Xie G, JCI Insight 2022 Feb 22;7(4):e150894   ⋅   Zheng W, Int J Cancer 2012 Jan 1;130(1):10-9

2 pathology image(s)

Intestine - Small Intestine adenoma Intestine - Small Intestine 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)

100

100

References: Steffensen IL, Carcinogenesis 1997 May;18(5):1049-54

Intestine - Small Intestine adenoma Intestine - Small Intestine fish oil

very high

very high

References: Paulsen JE, Carcinogenesis 1997 Oct;18(10):1905-10

Intestine - Small Intestine adenoma Intestine - Small Intestine ovariectomy

observed

References: Weyant MJ, Cancer Res 2001 Mar 15;61(6):2547-51

Intestine - Small Intestine adenoma Intestine - Small Intestine 17beta-estradiol (E2)   ⋅   ovariectomy

observed

References: Weyant MJ, Cancer Res 2001 Mar 15;61(6):2547-51

Intestine - Small Intestine adenoma - microadenoma Intestine - Small Intestine

observed

References: Qi C, Int J Biol Sci 2015;11(6):679-87

Intestine - Small Intestine dysplasia Intestine - Small Intestine

observed

References: Dudley ME, Int J Cancer 1996 Jan 17;65(2):249-53

Intestine - Small Intestine dysplasia - high grade Intestine - Small Intestine

5.26

References: Andrijes R, Proc Natl Acad Sci U S A 2021 Sep 28;118(39):

Intestine - Small Intestine dysplasia - low grade Intestine - Small Intestine

94.74

References: Andrijes R, Proc Natl Acad Sci U S A 2021 Sep 28;118(39):

Intestine - Small Intestine lesion Intestine - Small Intestine

observed

References: Andrijes R, Proc Natl Acad Sci U S A 2021 Sep 28;118(39):

Intestine - Small Intestine lesion - malignant Intestine - Small Intestine

0

References: Andrijes R, Proc Natl Acad Sci U S A 2021 Sep 28;118(39):

Intestine - Small Intestine polyp Intestine - Small Intestine

very high

observed - 100

References: Andrijes R, Proc Natl Acad Sci U S A 2021 Sep 28;118(39):   ⋅   Dudley ME, Int J Cancer 1996 Jan 17;65(2):249-53   ⋅   Gupta RA, Nat Med 2004 Mar;10(3):245-7   ⋅   Zeineldin M, Oncogene 2012 May 10;31(19):2423-37

Intestine - Small Intestine polyp Intestine - Small Intestine GW501516, PPAR-delta agonist

observed

References: Gupta RA, Nat Med 2004 Mar;10(3):245-7

Intestine - Small Intestine tumor Intestine - Small Intestine low fiber

100

References: Pierre F, Cancer Res 1997 Jan 15;57(2):225-8

Intestine - Small Intestine tumor Intestine - Small Intestine high fiber

100

References: Pierre F, Cancer Res 1997 Jan 15;57(2):225-8

Intestine - Small Intestine tumor Intestine - Small Intestine

observed

observed

observed - 100

observed - very high

References: Hansen-Petrik MB, Cancer Res 2002 Jan 15;62(2):403-8   ⋅   Ma H, Cell Rep 2020 Jan 21;30(3):793-806.e6   ⋅   Mahmoud NN, Carcinogenesis 1999 Feb;20(2):299-303   ⋅   Qi C, Int J Biol Sci 2015;11(6):679-87   ⋅   Ritland SR, Clin Cancer Res 1999 Apr;5(4):855-63   ⋅   Steffensen IL, Cancer Res 2001 Dec 15;61(24):8689-96   ⋅   Sun X, Mol Cancer 2009;8():73   ⋅   Ton-That H, FEBS Lett 1997 Dec 15;419(2-3):239-43   ⋅   Weyant MJ, Cancer Res 2001 Jan 1;61(1):118-25   ⋅   Williams JL, Biochem Biophys Res Commun 2004 Jan 16;313(3):784-8   ⋅   Xie G, JCI Insight 2022 Feb 22;7(4):e150894   ⋅   Ziegler CC, J Nutr 2004 Jan;134(1):5-10

Intestine - Small Intestine tumor Intestine - Small Intestine chenodeoxycholate (chenodeoxycholic acid)

observed

References: Mahmoud NN, Carcinogenesis 1999 Feb;20(2):299-303

Intestine - Small Intestine tumor Intestine - Small Intestine sulfasalazine (SASP)

observed

References: Ritland SR, Clin Cancer Res 1999 Apr;5(4):855-63

Intestine - Small Intestine tumor Intestine - Small Intestine Pentasa

observed

References: Ritland SR, Clin Cancer Res 1999 Apr;5(4):855-63

Intestine - Small Intestine tumor Intestine - Small Intestine 5-aminosalicylic acid, free acid (5-ASA)

observed

References: Ritland SR, Clin Cancer Res 1999 Apr;5(4):855-63

Intestine - Small Intestine tumor Intestine - Small Intestine (+)-catechin

observed

References: Weyant MJ, Cancer Res 2001 Jan 1;61(1):118-25

Intestine - Small Intestine tumor Intestine - Small Intestine piroxicam

observed

References: Hansen-Petrik MB, Cancer Res 2002 Jan 15;62(2):403-8

Intestine - Small Intestine tumor Intestine - Small Intestine 16,16-dimethyl-prostaglandin E2 (16,16dmPGE2)   ⋅   17-phenyl-trinor-prostaglandin E2

observed

References: Hansen-Petrik MB, Cancer Res 2002 Jan 15;62(2):403-8

Intestine - Small Intestine tumor Intestine - Small Intestine 16,16-dimethyl-prostaglandin E2 (16,16dmPGE2)   ⋅   piroxicam   ⋅   17-phenyl-trinor-prostaglandin E2

observed

References: Hansen-Petrik MB, Cancer Res 2002 Jan 15;62(2):403-8

Intestine - Small Intestine tumor Intestine - Small Intestine anti-prostaglandin E2 (PGE2monoclonal antibody 2B5)

observed

References: Hansen-Petrik MB, Cancer Res 2002 Jan 15;62(2):403-8

Intestine - Small Intestine tumor Intestine - Small Intestine 17-phenyl-trinor-prostaglandin E2

observed

References: Hansen-Petrik MB, Cancer Res 2002 Jan 15;62(2):403-8

Intestine - Small Intestine tumor Intestine - Small Intestine piroxicam   ⋅   17-phenyl-trinor-prostaglandin E2

observed

References: Hansen-Petrik MB, Cancer Res 2002 Jan 15;62(2):403-8

Intestine - Small Intestine tumor Intestine - Small Intestine sulindac

observed

References: Hansen-Petrik MB, Cancer Res 2002 Jan 15;62(2):403-8

Intestine - Small Intestine tumor Intestine - Small Intestine 16,16-dimethyl-prostaglandin E2 (16,16dmPGE2)   ⋅   sulindac   ⋅   17-phenyl-trinor-prostaglandin E2

observed

References: Hansen-Petrik MB, Cancer Res 2002 Jan 15;62(2):403-8

Intestine - Small Intestine tumor Intestine - Small Intestine 2-amino-1-methyl-6-phenylimidazo[4,5-b]pyridine (PhIP)

observed - 100

References: Steffensen IL, Cancer Res 2001 Dec 15;61(24):8689-96

Intestine - Small Intestine tumor Intestine - Small Intestine resveratrol

observed

References: Ziegler CC, J Nutr 2004 Jan;134(1):5-10

Intestine - Small Intestine tumor Intestine - Small Intestine 2-(acetyloxy)benzoic acid 4-(nitrooxy methyl)phenyl ester) (NO-ASA)

90

References: Williams JL, Biochem Biophys Res Commun 2004 Jan 16;313(3):784-8

Intestine adenocarcinoma Intestine

observed

References: Sun X, Mol Cancer 2009;8():73

Intestine adenoma Intestine high saturated fat

very high

References: Wechter WJ, Cancer Res 1997 Oct 1;57(19):4316-24

Intestine adenoma Intestine low saturated fat

very high

References: Wechter WJ, Cancer Res 1997 Oct 1;57(19):4316-24

Intestine adenoma Intestine high saturated fat   ⋅   R-flurbiprofen (R-FB) (E-7869)

very high

References: Wechter WJ, Cancer Res 1997 Oct 1;57(19):4316-24

Intestine adenoma Intestine low saturated fat   ⋅   R-flurbiprofen (R-FB) (E-7869)

very high

References: Wechter WJ, Cancer Res 1997 Oct 1;57(19):4316-24

Intestine adenoma Intestine

0 - 100

observed

observed

observed

References: Boolbol SK, Cancer Res 1996 Jun 1;56(11):2556-60   ⋅   Chen Q, Life Sci Alliance 2021 Mar;4(3):   ⋅   Goss KJ, Int J Cancer 1998 Nov 23;78(5):629-35   ⋅   Guillen-Ahlers H, Carcinogenesis 2008 Jul;29(7):1421-7   ⋅   Gutierrez LS, Carcinogenesis 2003 Feb;24(2):199-207   ⋅   He XY, Cell Rep 2015 Nov 3;13(5):888-97   ⋅   Heuberger J, Life Sci Alliance 2019 Feb;2(1):e201800173   ⋅   Mahmoud NN, Carcinogenesis 1998 Jan;19(1):87-91   ⋅   Mahmoud NN, Carcinogenesis 2000 May;21(5):921-7   ⋅   Maywald RL, Proc Natl Acad Sci U S A 2015 May 12;112(19):E2487-96   ⋅   Nakatsugi S, Jpn J Cancer Res 1997 Dec;88(12):1117-20   ⋅   Ritland SR, Cancer Res 2000 Sep 1;60(17):4678-81   ⋅   Schmelz EM, Cancer Res 2001 Sep 15;61(18):6723-9   ⋅   Steinbrecher KA, Biochem Biophys Res Commun 2000 Jun 24;273(1):225-30   ⋅   Thompson JA, Int J Cancer 1997 Jul 3;72(1):197-202   ⋅   Wagenaar-Miller RA, Br J Cancer 2003 May 6;88(9):1445-52   ⋅   Weyant MJ, Cancer Res 2001 Jan 1;61(1):118-25   ⋅   Weyant MJ, Cancer Res 2001 Mar 15;61(6):2547-51   ⋅   Yamada T, Cancer Res 2003 Mar 1;63(5):895-901   ⋅   Zheng W, Int J Cancer 2012 Jan 1;130(1):10-9

Intestine adenoma Intestine sulindac sulfide

30

References: Mahmoud NN, Carcinogenesis 1998 Jan;19(1):87-91

Intestine adenoma Intestine sulindac sulfone

100

References: Mahmoud NN, Carcinogenesis 1998 Jan;19(1):87-91

Intestine adenoma Intestine caffeic acid phenethyl ester (CAPE)

very high

References: Mahmoud NN, Carcinogenesis 2000 May;21(5):921-7

Intestine adenoma Intestine curcumin

very high

References: Mahmoud NN, Carcinogenesis 2000 May;21(5):921-7

Intestine adenoma Intestine quercetin

very high

References: Mahmoud NN, Carcinogenesis 2000 May;21(5):921-7

Intestine adenoma Intestine rutin

very high

References: Mahmoud NN, Carcinogenesis 2000 May;21(5):921-7

Intestine adenoma Intestine N-[4-(3-chloro-4-fluoro-phenylamino)-quinazolin-6-yl]acrylamide (CFPQA)

observed

References: Ritland SR, Cancer Res 2000 Sep 1;60(17):4678-81

Intestine adenoma Intestine (+)-catechin

observed

References: Weyant MJ, Cancer Res 2001 Jan 1;61(1):118-25

Intestine adenoma Intestine ceramide (N-palmitoylsphingosine)

observed

References: Schmelz EM, Cancer Res 2001 Sep 15;61(18):6723-9

Intestine adenoma Intestine sphingolipid mix

observed

References: Schmelz EM, Cancer Res 2001 Sep 15;61(18):6723-9

Intestine adenoma Intestine sphingolipid mix   ⋅   ceramide (N-palmitoylsphingosine)

observed

References: Schmelz EM, Cancer Res 2001 Sep 15;61(18):6723-9

Intestine adenoma Intestine piroxicam

observed

References: Ritland SR, Cancer Res 2000 Sep 1;60(17):4678-81

Intestine adenoma Intestine ovariectomy

observed

References: Weyant MJ, Cancer Res 2001 Mar 15;61(6):2547-51

Intestine adenoma Intestine 17beta-estradiol (E2)   ⋅   ovariectomy

observed

References: Weyant MJ, Cancer Res 2001 Mar 15;61(6):2547-51

Intestine adenoma Intestine A-177430, MMP inhibitor

observed

References: Wagenaar-Miller RA, Br J Cancer 2003 May 6;88(9):1445-52

Intestine adenoma Intestine A-285969, Cox-2 inhibitor

observed

References: Wagenaar-Miller RA, Br J Cancer 2003 May 6;88(9):1445-52

Intestine adenoma Intestine sulindac

observed

observed

References: Guillen-Ahlers H, Carcinogenesis 2008 Jul;29(7):1421-7   ⋅   Wagenaar-Miller RA, Br J Cancer 2003 May 6;88(9):1445-52

Intestine adenoma Intestine A-177430, MMP inhibitor   ⋅   A-285969, Cox-2 inhibitor

observed

References: Wagenaar-Miller RA, Br J Cancer 2003 May 6;88(9):1445-52

Intestine adenoma Intestine nimesulide (4-nitro-2-phenoxymethanesulfonanilide)

observed

References: Nakatsugi S, Jpn J Cancer Res 1997 Dec;88(12):1117-20

Intestine adenoma Intestine batimastat (BB-94)

observed

References: Goss KJ, Int J Cancer 1998 Nov 23;78(5):629-35

Intestine adenoma Intestine low saturated fat   ⋅   S-flurbiprofen (S-FB)

very high

References: Wechter WJ, Cancer Res 1997 Oct 1;57(19):4316-24

Intestine lesion Intestine

observed

References: Andrijes R, Proc Natl Acad Sci U S A 2021 Sep 28;118(39):

Intestine polyp Intestine uroguanylin   ⋅   polyethylene glycol

observed

References: Shailubhai K, Cancer Res 2000 Sep 15;60(18):5151-7

Intestine polyp Intestine polyethylene glycol

observed

References: Shailubhai K, Cancer Res 2000 Sep 15;60(18):5151-7

Intestine polyp Intestine

observed

observed - 100

References: Andrijes R, Proc Natl Acad Sci U S A 2021 Sep 28;118(39):   ⋅   He XY, Cell Rep 2015 Nov 3;13(5):888-97   ⋅   Heuberger J, Life Sci Alliance 2019 Feb;2(1):e201800173   ⋅   Maywald RL, Proc Natl Acad Sci U S A 2015 May 12;112(19):E2487-96   ⋅   Mutoh M, Cancer Res 2002 Jan 1;62(1):28-32   ⋅   Qi C, Int J Biol Sci 2015;11(6):679-87   ⋅   Wang X, Oncogene 2017 Aug 31;36(35):4987-4996

Intestine polyp Intestine 2-[2-{2-(1-naphthyl)propanoylamino}phenyl]methylbenzoic acid (ONO-AE2-227)

observed

References: Mutoh M, Cancer Res 2002 Jan 1;62(1):28-32

Intestine polyp Intestine anti-IL1RL1 (mu-IgG1-FC?anti-muST2, Amgen)

observed

References: Maywald RL, Proc Natl Acad Sci U S A 2015 May 12;112(19):E2487-96

Intestine polyp Intestine anti-IgG (4D2-mu-IgG1?anti-huAGP3-Pb, Amgen)

observed

References: Maywald RL, Proc Natl Acad Sci U S A 2015 May 12;112(19):E2487-96

Intestine polyp - adenomatous Intestine

observed

References: Maywald RL, Proc Natl Acad Sci U S A 2015 May 12;112(19):E2487-96   ⋅   Zheng W, Int J Cancer 2012 Jan 1;130(1):10-9

Intestine tumor Intestine

observed - 100

observed

observed

observed - 100

References: Andrijes R, Proc Natl Acad Sci U S A 2021 Sep 28;118(39):   ⋅   Barnes CJ, Gastroenterology 1998 May;114(5):873-7   ⋅   Boolbol SK, Cancer Res 1996 Jun 1;56(11):2556-60   ⋅   Dudley ME, Int J Cancer 1996 Jan 17;65(2):249-53   ⋅   Heuberger J, Life Sci Alliance 2019 Feb;2(1):e201800173   ⋅   Lefebvre AM, Nat Med 1998 Sep;4(9):1053-7   ⋅   Maywald RL, Proc Natl Acad Sci U S A 2015 May 12;112(19):E2487-96   ⋅   Moser AR, Cancer Res 2001 Apr 15;61(8):3480-5   ⋅   Oster H, Cancer Res 2006 Jul 15;66(14):6955-63   ⋅   Qi C, Int J Biol Sci 2015;11(6):679-87   ⋅   Ritland SR, Clin Cancer Res 1999 Apr;5(4):855-63   ⋅   Wang X, Oncogene 2017 Aug 31;36(35):4987-4996   ⋅   Wilson CL, Proc Natl Acad Sci U S A 1997 Feb 18;94(4):1402-7   ⋅   Zheng W, Int J Cancer 2012 Jan 1;130(1):10-9

Intestine tumor Intestine piroxicam

observed

References: Ritland SR, Clin Cancer Res 1999 Apr;5(4):855-63

Intestine tumor Intestine sulindac

10

observed

References: Boolbol SK, Cancer Res 1996 Jun 1;56(11):2556-60   ⋅   Ritland SR, Clin Cancer Res 1999 Apr;5(4):855-63

Intestine tumor Intestine 5-aminosalicylic acid, free acid (5-ASA)

observed

References: Ritland SR, Clin Cancer Res 1999 Apr;5(4):855-63

Intestine tumor Intestine 4-aminosalicylic acid, sodium salt (4-ASA)

observed

References: Ritland SR, Clin Cancer Res 1999 Apr;5(4):855-63

Intestine tumor Intestine Pentasa

observed

References: Ritland SR, Clin Cancer Res 1999 Apr;5(4):855-63

Intestine tumor Intestine sulfasalazine (SASP)

observed

References: Ritland SR, Clin Cancer Res 1999 Apr;5(4):855-63

Intestine tumor Intestine BRL-49,653, PPAR gamma ligand

observed

References: Lefebvre AM, Nat Med 1998 Sep;4(9):1053-7

Intestine tumor Intestine troglitazone

observed

References: Lefebvre AM, Nat Med 1998 Sep;4(9):1053-7

Intestine tumor Intestine aspirin (acetylsalicylic acid) (ASA)

observed

References: Barnes CJ, Gastroenterology 1998 May;114(5):873-7

Intestine tumor Intestine anti-IL1RL1 (mu-IgG1-FC?anti-muST2, Amgen)

observed

References: Maywald RL, Proc Natl Acad Sci U S A 2015 May 12;112(19):E2487-96

Intestine tumor Intestine anti-IgG (4D2-mu-IgG1?anti-huAGP3-Pb, Amgen)

observed

References: Maywald RL, Proc Natl Acad Sci U S A 2015 May 12;112(19):E2487-96

Intestine tumor Intestine tamoxifen (for inducing expression from mutant alleles)

observed

References: Powell AE, Am J Physiol Gastrointest Liver Physiol 2014 Jul 1;307(1):G16-23

Intestine tumor - epithelial Intestine

observed

References: Wang X, Oncogene 2017 Aug 31;36(35):4987-4996

Stomach polyp Stomach

45.45

References: Zeineldin M, Oncogene 2012 May 10;31(19):2423-37